HLA antigens in Guillain-Barré syndrome. 1984

R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams

We compared Guillain-Barré syndrome (GBS) cases reported from cities in the United States in 1976-1977 with spouse or associate controls to detect possible HLA associations. HLA-A11 was somewhat less common among 92 cases than among 100 controls (p = 0.04). The 38 patients and 42 controls vaccinated against A/NJ/76 differed slightly in overall distribution of B locus antigens (p = 0.06), but the individual HLA-B antigen associations were more easily explained by chance. The 54 unvaccinated cases showed no apparent relation to HLA type. These findings should encourage further immunogenetic study of etiologically related GBS cases.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
September 1985, Journal of neurogenetics,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
September 1977, Lancet (London, England),
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
June 1992, Journal of neurology, neurosurgery, and psychiatry,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
April 1988, Journal of neuroimmunology,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
July 1995, Neurology,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
February 1983, Journal of neuroimmunology,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
September 1978, Annals of neurology,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
May 1979, Neurology,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
March 2012, Journal of the peripheral nervous system : JPNS,
R A Kaslow, and J Z Sullivan-Bolyai, and B Hafkin, and L B Schonberger, and L Kraus, and M J Moore, and E Yunis, and R M Williams
April 1986, Neurochemical pathology,
Copied contents to your clipboard!